Invesco S&P MidCap 400 Pu... (RFG)
NYSEArca: RFG
· Prix en temps réel · USD
64.15
+0.52 (0.82%)
À la clôture : Aug 14, 2026, 3:50 PM
64.18
+0.04%
Après-Bourse: 7:34 PM
Invesco S&P MidCap 400 Pure Growth ETF (RFG) ETF Price, Holdings & Analysis
0.82% (1D)
| Bid | n / A |
| Capitalisation boursière | n/a |
| AUM | 338.67M |
| NAV | 63.03 |
| Bêta | 1.09 |
| EPS (ttm) | n / A |
| Rapport PE (ttm) | 28.48 |
| Parts en circulation | n / A |
| Date de création | Mar 1, 2006 |
| Ask | n / A |
| Volume | 30,801 |
| Moy. Volume (20D) | 6,696 |
| Ouverture | 63.86 |
| Clôture précédente | 63.63 |
| Fourchette du jour | 63.81 - 64.20 |
| Intervalle de 52 semaines | 49.19 - 64.81 |
| Positions | n / A |
| Ratio de frais | 0.35% |
À propos de RFG
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index is composed of a subset of securities from the S&P MidCap 400® Index that exhibit strong growth characteristics.
Classe d’actifs Equity
Symbole boursier RFG
Date de création Mar 1, 2006
Fournisseur Invesco
Site web Page d’accueil du fonds
Échange NYSEArca
Principaux secteurs
| Secteur | Poids % |
|---|---|
| Industrials | 28.91% |
| Healthcare | 23.22% |
| Technology | 20.83% |
| Consumer Cyclical | 6.88% |
| Energy | 4.44% |
10 principaux titres 20.36% des actifs
| Nom | Symbole | Poids |
|---|---|---|
| Arrowhead Pharmaceut... | ARWR | 2.52% |
| Sterling Infrastruct... | STRL | 2.32% |
| Carpenter Technology... | CRS | 2.25% |
| Technipfmc PLC | FTI | 2.18% |
| Halozyme Therapeutic... | HALO | 2.09% |
| Digitalocean Holding... | DOCN | 1.90% |
| Woodward Inc | WWD | 1.84% |
| Medpace Holdings Inc | MEDP | 1.80% |
| Interdigital Inc | IDCC | 1.74% |
| Ati Inc | ATI | 1.72% |
Dividendes Rendement du dividende 0.14%
| Ex-dividende | Montant | Date de paiement |
|---|---|---|
| Jun 22, 2026 | $0.0080 | n / A |
| Mar 23, 2026 | $0.0110 | n / A |
| Dec 22, 2025 | $0.0290 | n / A |
| Sep 22, 2025 | $0.0410 | n / A |
| Jun 23, 2025 | $0.1200 | n / A |
Page 1 de 2
